Will there be differences in Complete Blood Count (CBC), Activated Partial Thromboplastin Time (APTT), and Prothrombin Time (PT) in a patient undergoing dialysis, both during and after the procedure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Changes in CBC, APTT, and PT During and After Dialysis

Yes, there are measurable differences in CBC parameters and coagulation studies (APTT, PT) both during and after dialysis, primarily due to heparin anticoagulation, hemodilution effects, and the timing of blood sampling.

Complete Blood Count (CBC) Changes

Hemoglobin and Hematocrit

  • Hemoglobin, hematocrit, and red blood cell count increase after both hemodialysis and peritoneal dialysis due to ultrafiltration removing plasma volume while concentrating cellular elements 1
  • The increase in these parameters reflects hemoconcentration rather than true red cell mass expansion 1
  • Timing of post-dialysis sampling is critical: immediate post-dialysis samples may show falsely elevated values due to incomplete equilibration, while samples drawn 30-60 minutes later allow for fluid redistribution 2

White Blood Cells and Platelets

  • Leukocyte and platelet counts show mild increases after hemodialysis 1
  • These changes are transient and related to hemoconcentration effects 1

Mean Corpuscular Values

  • Mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) show mild increases after peritoneal dialysis but slight decreases after hemodialysis 1

Coagulation Studies (APTT and PT) Changes

APTT Prolongation During Dialysis

  • APTT is significantly prolonged during and immediately after hemodialysis due to heparin anticoagulation used to prevent circuit clotting 1, 2
  • Low-molecular-weight heparin (half-life ~4 hours) and unfractionated heparin (half-life 1-2 hours) are the most common anticoagulants used during dialysis 2
  • The anticoagulant effect can be minimized by performing procedures on non-dialysis days or the day after hemodialysis, allowing heparin to clear 2

PT Prolongation

  • PT is also significantly prolonged after dialysis sessions 1
  • The degree of PT prolongation is less pronounced than APTT changes, as heparin primarily affects the intrinsic pathway (monitored by APTT) 3

Recovery Timeline

  • APTT typically normalizes within 4-6 hours post-dialysis as heparin is metabolized, depending on the type of heparin used 2
  • Unfractionated heparin clears more rapidly (1-2 hours) compared to low-molecular-weight heparin (4 hours) 2

Critical Timing Considerations for Blood Sampling

Pre-Dialysis Sampling

  • Pre-dialysis samples should be drawn before any saline or heparin administration to avoid dilution artifacts that falsely lower values 2
  • Drawing samples after dialysis initiation will show artificially lowered BUN and other parameters due to immediate dilution effects 2

Post-Dialysis Sampling

  • The optimal timing for post-dialysis sampling is 2-5 minutes after dialysis completion using the slow flow/stop pump technique to minimize urea rebound effects 2
  • Samples drawn immediately (0 minutes) may contain recirculated blood with falsely low values 2
  • Samples drawn after blood reinfusion (5-10 minutes) show partial equilibration with higher BUN and normalized CBC values 2
  • Saline reinfusion at treatment end (150-500 mL) can dilute plasma and lower concentrations, particularly affecting small patients 2

Clinical Implications and Recommendations

For Surgical or Invasive Procedures

  • Schedule elective procedures on non-dialysis days or the day after hemodialysis to minimize bleeding risk from residual heparin effect 2
  • Check coagulation studies (PT, APTT) before any invasive procedure to ensure adequate hemostasis 2
  • Bleeding times >10-15 minutes are associated with high hemorrhage risk and require correction before procedures 2

Laboratory Monitoring Strategy

  • Obtain pre-dialysis CBC and coagulation studies before heparin administration for accurate baseline values 1
  • For post-dialysis assessment, wait at least 4-6 hours after dialysis to allow heparin clearance and fluid equilibration before drawing coagulation studies 2
  • If immediate post-dialysis values are needed, use standardized timing (2-5 minutes post-completion) and interpret with awareness of ongoing hemoconcentration and anticoagulation effects 2

Common Pitfalls to Avoid

  • Do not interpret immediate post-dialysis CBC values as true steady-state values—they reflect hemoconcentration 1
  • Do not perform invasive procedures within 4-6 hours of dialysis without checking coagulation studies, as residual heparin effect persists 2
  • Avoid drawing samples from the arterial port during dialysis as this may contain recirculated blood with inaccurate values 2
  • Do not use post-dialysis APTT/PT values to guide long-term anticoagulation decisions as they reflect transient heparin effects rather than baseline coagulation status 1, 3

References

Research

Hematological changes post-hemo and peritoneal dialysis among renal failure patients in Sudan.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.